- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05625789
How to Get Started: Identifying the Critical Ingredients to Improve Gait Initiation in Parkinson Disease
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- UNC Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of idiopathic Parkinson disease characterized by asymmetrical onset of at least 2 of 3 cardinal signs (resting tremor, bradykinesia, or rigidity) with no atypical signs or exposure to dopamine-blocking drugs
- The presence of mild to moderate gait or balance impairment (a rating of 1-2 on MDS Unified Parkinson Disease Rating Scale (MDS-UPDRS) item 10 [gait] or rating 1-3 on item 12 [postural stability]
- Hoehn & Yahr stages 1-3 ("on" for those who fluctuate)
- Self-report of difficulty with freezing of gait (i.e., a rating of 1-4 on question 3 of the Freezing of Gait Questionnaire)
- All participants must be able to walk > 5 minutes at greater than or equal to 80% of comfortable gait speed (CGS) on the treadmill and > 5 minutes over ground without assistance or an assistive device.
Exclusion Criteria:
- Uncontrolled cardiorespiratory/metabolic disease, vestibular dysfunction that may affect gait or balance
- Parkinson's related or unrelated dementia (i.e. Montreal Cognitive Assessment score <21)
- Comfortable over ground walking speed of less than 0.5m/s
- History of traumatic brain injury
- self-reported deafness or blindness as this would impair the patient's ability to hear cues or ambulate safely within the lab environment
- other neurological disorders or orthopedic injury that may affect gait
- recent orthopedic surgery (in the last 6 months)
- Participants will also be excluded if they have severe communication impairments, which could impede understanding of the purpose or procedures of the study or an inability to comply with experimental procedures
- Participants who are currently receiving supervised physical therapy services
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Postural control (weight shifting) training followed by steady state gait training.
For postural control training, participants will be provided visual biofeedback to increase weight shift prior to the first step. The feedback program cues participants to reach a target amount of weight shift. Once the target is reached, participants are cued to initiate walking. Participants will complete a total of 30 minutes of training, ensuring at least 45 repetitions. To create larger amplitude movements during steady state gait, participants will walk on a treadmill set to their comfortable gait speed while attempting to match their steps to a metronome beeping at 85% of their comfortable cadence. Participants will complete a total of 10 minutes of treadmill walking with rest breaks as needed. Next, participants will walk overground to a metronome beeping at 115% of their comfortable cadence with a goal of 10 total minutes of training. Each training will be three times per week for two weeks. There is a one week break between the two trainings. |
Visual cues to improve amplitude of weight shift prior to initiating gait.
Auditory cues are provided to increase amplitude of movement (e.g., step length) during continuous walking, to determine its effects on gait initiation amplitude of movement.
|
|
Experimental: Steady state gait training followed by postural control (weight shifting) training.
To create larger amplitude movements during steady state gait, participants will walk on a treadmill set to their comfortable gait speed while attempting to match their steps to a metronome beeping at 85% of their comfortable cadence. Participants will complete a total of 10 minutes of treadmill walking with rest breaks as needed. Next, participants will walk overground to a metronome beeping at 115% of their comfortable cadence with a goal of 10 total minutes of training. For postural control training, participants will be provided visual biofeedback to increase weight shift prior to the first step. The feedback program cues participants to reach a target amount of weight shift. Once the target is reached, participants are cued to initiate walking. Participants will complete a total of 30 minutes of training, ensuring at least 45 repetitions. Each training will be three times per week for two weeks. There is a one week break between the two trainings. |
Visual cues to improve amplitude of weight shift prior to initiating gait.
Auditory cues are provided to increase amplitude of movement (e.g., step length) during continuous walking, to determine its effects on gait initiation amplitude of movement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in First Step Length from Baseline to Conclusion of the first block of training
Time Frame: Baseline, at the conclusion of the first block of training (approximately 2 weeks)
|
Length of the first step during gait initiation (i.e., distance from stepping limb heel marker at quiet stance to heel marker of stepping limb at heel strike of the first step forward).
|
Baseline, at the conclusion of the first block of training (approximately 2 weeks)
|
|
Change in First Step Length from end of first block of training to training 2 pre-test
Time Frame: Conclusion of first training block, just prior to beginning the second training series (1 week)
|
Length of the first step during gait initiation (i.e., distance from stepping limb heel marker at quiet stance to heel marker of stepping limb at heel strike of the first step forward).
|
Conclusion of first training block, just prior to beginning the second training series (1 week)
|
|
Change in First Step Length from training block 2 pre-test to conclusion of second block of training
Time Frame: Prior to beginning second block of training, at the conclusion of second block of training (2 weeks)
|
Length of the first step during gait initiation (i.e., distance from stepping limb heel marker at quiet stance to heel marker of stepping limb at heel strike of the first step forward).
|
Prior to beginning second block of training, at the conclusion of second block of training (2 weeks)
|
|
Change in First Step Length from conclusion of second training block to 1 week follow up from second training block
Time Frame: Conclusion of second training block, 1 week follow up from conclusion of second training block (1 week)
|
Length of the first step during gait initiation (i.e., distance from stepping limb heel marker at quiet stance to heel marker of stepping limb at heel strike of the first step forward).
|
Conclusion of second training block, 1 week follow up from conclusion of second training block (1 week)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mediolateral Anticipatory Postural Adjustment (APA) Size from Baseline to Conclusion of the first block of training
Time Frame: Baseline, at the conclusion of the first block of training (approximately 2 weeks)
|
Center of pressure displacement towards the stepping limb from quiet stance until toe off of the stepping limp (i.e., the initiation of gait).
|
Baseline, at the conclusion of the first block of training (approximately 2 weeks)
|
|
Change in Mediolateral Anticipatory Postural Adjustment (APA) Size from end of first block of training to training 2 pre-test
Time Frame: Conclusion of first training block, just prior to beginning the second training series (1 week)
|
Center of pressure displacement towards the stepping limb from quiet stance until toe off of the stepping limp (i.e., the initiation of gait).
|
Conclusion of first training block, just prior to beginning the second training series (1 week)
|
|
Change in Mediolateral Anticipatory Postural Adjustment (APA) Size from training block 2 pre-test to conclusion of second block of training
Time Frame: Prior to beginning second block of training, at the conclusion of second block of training (2 weeks)
|
Center of pressure displacement towards the stepping limb from quiet stance until toe off of the stepping limp (i.e., the initiation of gait).
|
Prior to beginning second block of training, at the conclusion of second block of training (2 weeks)
|
|
Change in Mediolateral Anticipatory Postural Adjustment (APA) Size from conclusion of second training block to 1 week follow up from second training block
Time Frame: Conclusion of second training block, 1 week follow up from conclusion of second training block (1 week)
|
Center of pressure displacement towards the stepping limb from quiet stance until toe off of the stepping limp (i.e., the initiation of gait).
|
Conclusion of second training block, 1 week follow up from conclusion of second training block (1 week)
|
|
Change in First Step Speed from Baseline to Conclusion of the first block of training
Time Frame: Baseline, at the conclusion of the first block of training (approximately 2 weeks)
|
First step speed is measured by dividing the first step length by the time it takes to take the first step - which is calculated as the time from toe off of the stepping limb to heel strike of the stepping limb.
|
Baseline, at the conclusion of the first block of training (approximately 2 weeks)
|
|
Change in First Step Speed from end of first block of training to training 2 pre-test
Time Frame: Conclusion of first training block, just prior to beginning the second training series (1 week)
|
First step speed is measured by dividing the first step length by the time it takes to take the first step - which is calculated as the time from toe off of the stepping limb to heel strike of the stepping limb.
|
Conclusion of first training block, just prior to beginning the second training series (1 week)
|
|
Change in First Step Speed from training block 2 pre-test to conclusion of second block of training
Time Frame: Prior to beginning second block of training, at the conclusion of second block of training (2 weeks)
|
First step speed is measured by dividing the first step length by the time it takes to take the first step - which is calculated as the time from toe off of the stepping limb to heel strike of the stepping limb.
|
Prior to beginning second block of training, at the conclusion of second block of training (2 weeks)
|
|
Change in First Step Speed from from conclusion of second training block to 1 week follow up from second training block
Time Frame: Conclusion of second training block, 1 week follow up from conclusion of second training block (1 week)
|
First step speed is measured by dividing the first step length by the time it takes to take the first step - which is calculated as the time from toe off of the stepping limb to heel strike of the stepping limb.
|
Conclusion of second training block, 1 week follow up from conclusion of second training block (1 week)
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Michael Lewek, PhD, UNC Chapel Hill
- Principal Investigator: Chelsea P Duppen, DPT, UNC Chapel Hill
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-2628
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.